Evaluation of Serum Apolipoprotein E as a Potential Biomarker for Pharmacological Therapeutic Efficacy Monitoring in Dopamine Dictated Disease Spectrum of Schizophrenia and Parkinson’s disease: A Preliminary Study

AIM OF THE STUDY: Parkinson’s disease and schizophrenia are disease end points of dopaminergic deficit and hyperactivity, respectively, in the mid brain. Accordingly, current medications aim to restore normal dopamine levels, overshooting of which results in adverse effects of psychosis and extra-py...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Ashish Kumar, Rani, Komal, Swarnkar, Surabhi, Kumar, Gaurav Khunger, Khan, Mohd Imran, Pokhriyal, Ruchika, Kumar, Domada Ratna, Goyal, Vinay, Tripathi, Manjari, Gupta, Rishab, Chadda, Rakesh Kumar, Vanamail, Perumal, Hariprasad, Gururao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178121/
https://www.ncbi.nlm.nih.gov/pubmed/30327579
http://dx.doi.org/10.1177/1179573518803585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178121/
https://www.ncbi.nlm.nih.gov/pubmed/30327579
http://dx.doi.org/10.1177/1179573518803585

Ejemplares similares